Publications

Integrative clinical and preclinical studies identify FerroTerminator1 as a potent therapeutic drug for MASH

 82
Integrative clinical and preclinical studies identify FerroTerminator1 as a potent therapeutic drug for MASH

Tags:

Previous Article

Human Schwann cell lipid dysregulation and plasma membrane perturbation in Charc...

Next Article

FerroTerminator1 as a potent therapeutic drug for MASH

Related Posts

Dopaminergic circuits controlling threat and safety learning

Dopaminergic circuits controlling threat and safety lea...

 117

Feeding gut microbes to nourish the brain: unravelling the diet–microbiota– gut–brain axis

Feeding gut microbes to nourish the brain: unravelling ...

 849

Prefrontal synaptic regulation of homeostatic sleep pressure revealed through synaptic chemogenetics

Prefrontal synaptic regulation of homeostatic sleep pre...

 77